Analysis of PARP1/2 in ovarian carcinoma has been done thoroughly, and different studies have evaluated immunohistological PARP1/2 expression and its association with BRCA mutational status or survival and have found a positive correlation [38, 39]. The gene discussed is PARP1; the disease is ovarian carcinoma.